Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 3 of 89 for:    resveratrol

Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Manuel González Ortiz, University of Guadalajara
ClinicalTrials.gov Identifier:
NCT02114892
First received: April 11, 2014
Last updated: NA
Last verified: April 2014
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2013
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Publications: